News

Phantomics Selected for the Ministry of SMEs and Startups' TIPS Global Marketing Program

Phantomics (CEOs Byoung Wook Choi and Pan Ki Kim), a medical AI startup, announced on December 9 that it has been selected as a TIPS (Tech Incubator Program for Startups) Global Marketing company by Korea's Ministry of SMEs and Startups. The program provides overseas-expansion funding to startups with high potential in international markets.


Phantomics previously developed a standardized quantitative biomarker solution based on medical imaging through the TIPS commercialization and technology-startup support programs, and the company said this work was highly evaluated in the latest selection. The selection brings roughly KRW 85 million in government support.


Phantomics combines AI with non-invasive diagnostics such as MRI and CT to deliver fast and accurate results. Its solution Myomics uses AI to reduce cardiac MRI analysis time from about 30 minutes to under two minutes while providing biopsy-level diagnostic accuracy, enabling safe and accurate diagnosis of suspected myocardial diseases such as heart failure, myocardial infarction, myocarditis and amyloidosis.


Myomics is in use at Severance Hospital, Seoul National University Hospital, Asan Medical Center and Seoul St. Mary's Hospital, as well as in Japan, China, Taiwan and Singapore. It has obtained approval from Korea's Ministry of Food and Drug Safety (MFDS) and clearances in Thailand, Taiwan, Malaysia and from the U.S. FDA.


In June, Phantomics established a U.S. subsidiary in Boston and is accelerating its entry into the U.S. market.

⚡ Made with pagesss